Skip to main content
Back to Y Combinator

Y Combinator's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by Y Combinator. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$112.0M

Pharmaceutical Portfolio Companies (5)

Export
Artificial Intelligence (AI)BiopharmaBiotechnologyClinical TrialsData ManagementHealth CareMachine LearningMedicalPharmaceuticalSimulation

BioStack is a digital platform that provides healthcare AI training environments and curated multimodal clinical datasets.

San Francisco, United States
October 2026
$9.5M
Seed

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyIndustrial AutomationManufacturingPersonal HealthPharmaceuticalRobotics

Multiply Labs develops robotic systems for automating biologics manufacturing.

San Francisco, United States
October 2026
$75.0M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalPharmaceutical

Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.

Oxford, United Kingdom
October 2026
$27.0M
Series A

Founder Contacts

41,000+ verified contacts

Advanced MaterialsArtificial Intelligence (AI)BiopharmaBiotechnologyGeneticsHealth CarePharmaceuticalTherapeutics

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

Altrincham, United Kingdom
June 2026
Pre-Seed

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyCloud ComputingHealth CareLife ScienceMachine LearningManufacturingPharmaceuticalSoftware

AbInitio Bio develops AI foundation models for biologic drug manufacturability and process optimization.

San Francisco, United States
May 2026
$500K
Pre-Seed

Founder Contacts

41,000+ verified contacts

Explore Y Combinator's Full Portfolio

View all companies funded by Y Combinator across every industry and funding stage.

View Full Y Combinator Portfolio